Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 3Pancreatic Neoplasms 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 7Fluorouracil 5Cisplatin 5Leucovorin 3becatecarin 2Oxaliplatin 2Capecitabine 2trifluridine tipiracil drug combination 1trametinib 1titanium silicide 1spartalizumab 1seribantumab 1sargramostim 1pembrolizumab 1motexafin lutetium 1ixabepilone 1incomplete Freund's adjuvant 1durvalumab 1cediranib 1Trastuzumab 1Sutures 1Surgical Instruments 1Standard of Care 1S 1 (combination) 1Radiotherapy 1Radiosurgery 1Palonosetron 1Observation 1Liver Transplantation 1Ligation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Bile Duct Neoplasms × titanium silicide × Clear all
NCT01096745 2011-06-23

Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer

Gyeongsang National University Hospital

Phase 2 Terminated
78 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡